A NEW GANGLION-BLOCKING AGENT TRIAL OF 'CIBA 9295' IN MAN
- 7 June 1952
- journal article
- Published by Elsevier in The Lancet
- Vol. 259 (6719), 1144-1145
- https://doi.org/10.1016/s0140-6736(52)91043-x
Abstract
No abstract availableKeywords
This publication has 1 reference indexed in Scilit:
- Zur Pharmakologie des N,N,N′,N′-3-Pentamethyl-N,N′-diäthyl-3-aza-pentan-1,5-diammonium-dibromid (Ciba 9295), einer ganglionär hemmenden SubstanzCellular and Molecular Life Sciences, 1950